167 related articles for article (PubMed ID: 25173447)
1. Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
Oya H; Kanda M; Sugimoto H; Shimizu D; Takami H; Hibino S; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y
J Gastroenterol; 2015 May; 50(5):590-600. PubMed ID: 25173447
[TBL] [Abstract][Full Text] [Related]
2. Regulator of Calcineurin 1 Gene Isoform 4, Down-regulated in Hepatocellular Carcinoma, Prevents Proliferation, Migration, and Invasive Activity of Cancer Cells and Metastasis of Orthotopic Tumors by Inhibiting Nuclear Translocation of NFAT1.
Jin H; Wang C; Jin G; Ruan H; Gu D; Wei L; Wang H; Wang N; Arunachalam E; Zhang Y; Deng X; Yang C; Xiong Y; Feng H; Yao M; Fang J; Gu J; Cong W; Qin W
Gastroenterology; 2017 Sep; 153(3):799-811.e33. PubMed ID: 28583823
[TBL] [Abstract][Full Text] [Related]
3. Reduced Expression of Adherens Junctions Associated Protein 1 Predicts Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
Ezaka K; Kanda M; Sugimoto H; Shimizu D; Oya H; Nomoto S; Sueoka S; Tanaka Y; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1499-507. PubMed ID: 26122373
[TBL] [Abstract][Full Text] [Related]
4. Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.
Kanda M; Nomoto S; Oya H; Shimizu D; Takami H; Hibino S; Hashimoto R; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
J Exp Clin Cancer Res; 2014 Aug; 33(1):66. PubMed ID: 25096402
[TBL] [Abstract][Full Text] [Related]
5. Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma.
Tanaka Y; Kanda M; Sugimoto H; Shimizu D; Sueoka S; Takami H; Ezaka K; Hashimoto R; Okamura Y; Iwata N; Tanaka C; Yamada S; Fujii T; Nakayama G; Koike M; Nomoto S; Fujiwara M; Kodera Y
Int J Oncol; 2015; 46(6):2546-54. PubMed ID: 25892360
[TBL] [Abstract][Full Text] [Related]
6. Diabetes, an independent poor prognostic factor of non-B non-C hepatocellular carcinoma, correlates with dihydropyrimidinase-like 3 promoter methylation.
Umetsu S; Mizukami H; Saito T; Uchida C; Igawa A; Kudo K; Itabashi C; Osonoi S; Danyang G; Sasaki T; Yagihashi S; Hakamada K
Sci Rep; 2020 Jan; 10(1):1156. PubMed ID: 31980687
[TBL] [Abstract][Full Text] [Related]
7. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
8. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
9. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
10. Epigenomic profiling of DNA methylation for hepatocellular carcinoma diagnosis and prognosis prediction.
Zhang C; Ge S; Wang J; Jing X; Li H; Mei S; Zhang J; Liang K; Xu H; Zhang X; Zhang C
J Gastroenterol Hepatol; 2019 Oct; 34(10):1869-1877. PubMed ID: 31038805
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of DENND2D by promoter hypermethylation is associated with early recurrence of hepatocellular carcinoma.
Kanda M; Nomoto S; Oya H; Takami H; Hibino S; Hishida M; Suenaga M; Yamada S; Inokawa Y; Nishikawa Y; Asai M; Fujii T; Sugimoto H; Kodera Y
Int J Oncol; 2014 Jan; 44(1):44-52. PubMed ID: 24189587
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of GPR155 as a prognostic factor after curative resection of hepatocellular carcinoma.
Umeda S; Kanda M; Sugimoto H; Tanaka H; Hayashi M; Yamada S; Fujii T; Takami H; Niwa Y; Iwata N; Tanaka C; Kobayashi D; Fujiwara M; Kodera Y
BMC Cancer; 2017 Sep; 17(1):610. PubMed ID: 28863781
[TBL] [Abstract][Full Text] [Related]
13. Lysyl Oxidase Is Predictive of Unfavorable Outcomes and Essential for Regulation of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.
Zhu J; Huang S; Wu G; Huang C; Li X; Chen Z; Zhao L; Zhao Y
Dig Dis Sci; 2015 Oct; 60(10):3019-31. PubMed ID: 26048020
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of PDSS2 expression to stratify patients at risk for recurrence of hepatocellular carcinoma.
Kanda M; Sugimoto H; Nomoto S; Oya H; Shimizu D; Takami H; Hashimoto R; Sonohara F; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Int J Oncol; 2014 Nov; 45(5):2005-12. PubMed ID: 25189544
[TBL] [Abstract][Full Text] [Related]
15. The suppressive role and aberrent promoter methylation of BTG3 in the progression of hepatocellular carcinoma.
Lv Z; Zou H; Peng K; Wang J; Ding Y; Li Y; Ren X; Wang F; Chang R; Liang L; Ding Y
PLoS One; 2013; 8(10):e77473. PubMed ID: 24147003
[TBL] [Abstract][Full Text] [Related]
16. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
[TBL] [Abstract][Full Text] [Related]
17. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
[TBL] [Abstract][Full Text] [Related]
18. OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.
Wu D; Yang X; Peng H; Guo D; Zhao W; Zhao C; Zhou X
Carcinogenesis; 2017 Sep; 38(9):910-919. PubMed ID: 28911005
[TBL] [Abstract][Full Text] [Related]
19. Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.
Kuo CC; Shih YL; Su HY; Yan MD; Hsieh CB; Liu CY; Huang WT; Yu MH; Lin YW
World J Gastroenterol; 2015 Apr; 21(13):3960-9. PubMed ID: 25852282
[TBL] [Abstract][Full Text] [Related]
20. Methylation of PCDH19 predicts poor prognosis of hepatocellular carcinoma.
Zhang T; Guan G; Chen T; Jin J; Zhang L; Yao M; Qi X; Zou J; Chen J; Lu F; Chen X
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e352-e358. PubMed ID: 29749051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]